Citigroup resumed coverage on Medline with a new price target
$MDLN
Medical/Dental Instruments
Health Care
Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/11/2026 | $60.00 | Buy | Citigroup |
| 2/5/2026 | $55.00 | Buy | Tigress Financial |
| 1/21/2026 | $50.00 → $55.00 | Buy | BTIG Research |
| 1/12/2026 | $48.00 | Buy | Citigroup |
| 1/12/2026 | $38.00 | Neutral | BNP Paribas Exane |
| 1/12/2026 | $50.00 | Overweight | Analyst |
| 1/12/2026 | $50.00 | Overweight | Piper Sandler |
| 1/12/2026 | $48.00 | Overweight | Morgan Stanley |
Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growthNORTHFIELD, Ill., March 11, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced during a groundbreaking event this week that it plans to expand its national network of 45 distribution centers across the U.S. by constructing a new 1.2 million sq. ft. distribution center in Midlothian, Texas. The distribution center is to be fully operational in Q2 of 2027 and is the first new DC announced by Medline in 2026 and after its initial public offering in December of last year.
NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $41.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not
NORTHFIELD, Ill., March 9, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its Distribution Center of the Year and Safety, Awareness for Everyone (SAFE) Award recipients to its top-performing facilities. These awards are given to the top-performing Medline distribution centers in the United States across its four tiers of size, as determined by the sales volume distributed out of each facility. Medline has been providing these awards to its highest-performing
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00
Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00
BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
424B4 - Medline Inc. (0002046386) (Filer)
EFFECT - Medline Inc. (0002046386) (Filer)
S-1 - Medline Inc. (0002046386) (Filer)
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedli